Objective: Blood levels of cytokines are commonly elevated in severe congestive heart failure (CHF) and in coronary artery disease (CAD). While the adverse effects of cytokines on contractile function and myocardial cell integrity are well studied, little is known on whether cardiac cells are only targets or active players in these inflammatory reactions. Methods and results: We tested if human coronary artery endothelial cells (HCAEC) may become a source of cytokine and adhesion molecule expression when stimulated with bacterial lipopolysaccharide (LPS). Analysis of HCAEC supernatants by ELISA identified enhanced secretion of IL-6, IL-8, and MCP-1 while endothelin-1 was not increased. IL-1b, IL-10, or TNF-a were not detectable by ELISA while RT-PCR revealed enhanced mRNA expression of IL-1b and TNF-a but not IL-10. FACS analysis showed an LPS-induced upregulation of ICAM-1, VCAM, and ELAM-1. LFA-1 could not be detected. We further characterized receptors involved in LPS-induced signaling. Our results indicate that activation of HCAEC by LPS requires Toll-like receptor (TLR) 4. Pretreating the cells with the 3-hydroxy-3-methylglutaryl CoA (HMG CoA) reductase inhibitor Cerivastatin reduced IL-6 release. Conclusions: Taken together, our results indicate that activated HCAEC may act as inflammatory cells and thus directly contribute to the progression of CHF and CAD. 
. Introduction
patients with unstable angina that can identify patients who will benefit most from invasive management [7] . InflamGrowing evidence supports the role of local and sysmatory mediators such as cytokines can modulate cardiac temic inflammation as a common pathophysiological contractility and therefore might influence CHF progresmechanism in different cardiovascular diseases like sion [8] [9] [10] . Cytokines such as IL-1, IL-6, and TNF-a congestive heart failure (CHF) or coronary artery disease exerted negative inotropic effects in isolated cells and (CAD). Elevated plasma levels of cytokines like interhearts [11, 12] . leukin (IL-) 6 and Tumor Necrosis Factor (TNF-) a were While the contribution of pro-inflammatory cytokines to not only consistently detected in patients with CHF [1] [2] [3] progression of cardiovascular diseases is well established, but also in patients with stable or unstable angina and little is known about the sources of enhanced cytokine myocardial infarction [4] [5] [6] . Cytokine levels correlate with secretion and the signal transduction pathways within the the extent of New York Heart Association (NYHA) target cells. It was proposed that enhanced blood levels of functional classes, ventricular function and prognosis. In cytokines in CHF might originate from inadequate tissue CAD, the IL-6 level is a marker of increased mortality in perfusion of non-vital organs [13] . Circulating blood cells such as monocytes were also identified as a source for secretion of cytokines like IL-1, IL-6, and TNF-a [1, 14] .
However, there is growing evidence that cardiac cells are intercellular adhesion molecule (ICAM)-1, IgG (2 mg / ml; 1 not only targets but, following proper stimulation, contribDianova, Hamburg, Germany); mouse anti-human-vascular ute to cytokine secretion themselves [15, 16] .
cell adhesion molecule (VCAM), IgG (2 mg / ml; 1 Bacterial cell wall components like lipopolysaccharide Dianova, Hamburg, Germany); mouse anti-human-E-selec-(LPS) can activate inflammatory processes [11] cardiomyocytes [15, 22, 23] and elevated levels of LPS and Dako, Hamburg, Germany); FITC-labeled goat-antisoluble CD14 could be measured in patients with CHF mouse-IgG (15 mg / ml; Dianova, Hamburg, Germany). [24] [25] [26] .
The first cardiac cells that can come in contact with the 2 .3. Cell culture circulating LPS may be the coronary endothelial cells. However, whereas human umbilical endothelial cells HCAEC were obtained from Promo Cell (Heidelberg, (HUVEC) were shown to respond to LPS, only little is Germany). Cells were grown in endothelial cell growth known about the activation mechanisms of human cormedium (EBM-2; Clonetics, St. Katharinen, Germany) onary artery endothelial cells (HCAEC). As endothelial supplemented with EGM-2 (2% FCS, hydrocortisone, cells of different sources seem to be very heterogeneous human fibroblast growth factor, vascular endothelial [27,28], we aimed to identify inflammatory mediators growth factor, insulin-like growth-factor, ascorbic acid, produced by HCAEC and receptors involved in the sigepidermal growth factor, gentamicin / amphotericin-1000, naling mechanism. We will show that HCAEC, presumably heparin; Clonetics, St. Katharinen, Germany). After reachin a TLR4-dependent manner, respond to LPS leading to ing confluence, endothelial cells were detached from subsequent release of inflammatory cytokines like IL-6, culture flasks using Trypsin-EDTA, washed and resus-IL-8, and MCP-1 and enhanced expression of adhesion pended in complete medium. All experiments were done molecules like ICAM-1, VCAM, and ELAM-1. Moreover, with cells kept in culture between three and six passages. we will demonstrate that cytokine release can be partially
Human peripheral blood mononuclear cells (PBMC) inhibited by the HMG CoA reductase inhibitor Cerivaswere isolated from heparinized blood of healthy adult tatin. In conclusion, our data show that HCAEC can act as donors by Ficoll-Isopaque density gradient centrifugation. 'inflammatory cells'. We therefore propose that their Isolated PBMCs were washed in PBS and cultured in activation could exert negative effects on contractile RPMI 1640 containing 10% FCS, 100 U / ml penicillin and function of the failing heart. 100 mg / ml streptomycin (Biochrom, Berlin, Germany).
.4. Stimulation of cells with LPS

. Methods
Endothelial cells were seeded in 500 ml complete 2 .1. Reagents and buffers medium with a density of 20 000 cells / well in 24-well plates or in 1000 ml complete medium with a density of LPS was extracted from Salmonella friedenau with 40 000 cells / well in 12-well plates. After growing to phenol-chloroform-petroleum-ether as described [29] confluency, cells were washed once with complete (kindly provided by H. Brade, Research Center Borstel).
medium. Different amounts of LPS were diluted in comThe synthetic tetraacylated bisphosphate precursor of E.
plete cell culture medium and added to the cells. Control coli Lipid A (also known as Compound 406) was syncultures were incubated with complete medium only. After thesized as described [30] . Cerivastatin was obtained from 24 h, cell culture supernatants were collected and frozen at Bayer (Wuppertal, Germany and then pre-incubated for 30 min with complete medium ml 103 Taq Buffer, 0.4 ml 10 mM dNTP, 1.0 ml of each containing Compound 406 or Cerivastatin. Control cultures 10 mM Primer, 0.1 ml Taq Polymerase [5 U / ml], and 1.0 were incubated with complete medium alone. After 30 min ml cDNA). The following sets of primers were used to of pre-incubation, 10 or 100 ng / ml LPS was added and amplify specific cDNA fragments: b-Actin (sense: 59-cells were cultivated for 24 h. Cytokine content in cell AGCGGGAAATCGTGCGTG-39 and antisense: 59-culture supernatants was measured by ELISA.
CAGGGTACATGGTGGTGCC In all cell culture supernatants of unstimulated HCAEC, Germany) and resuspended in 100 ml PBS containing 0.1% a basal secretion of IL-6, IL-8, MCP-1, and ET-1 could be NaN (PBS-NaN ) and 10% normal human serum. Cells detected. Stimulation of HCAEC with different amounts of 3 3
were then incubated for 30 min with the primary anti-LPS for 24 h induced a dose-dependent increase in IL-6, bodies. Subsequently, cells were washed with PBS-NaN IL-8, and MCP-1 (Fig. 1A , B, C) but not of ET-1 (Fig.   3 and incubated with the secondary antibody for 30 min. 1D). As little as 1 ng / ml LPS led to a significant rise in After another washing step, cells were resuspended in cytokine release. Additionally, earlier (3, 6, 9 h) and later PBS-NaN containing 1.5% paraformaldehyde. All sam-(48 h) time points have been analyzed. A detectable 3 ples were analyzed with FACS Calibur (Becton Dickinson, increase in IL-6, IL-8, and MCP-1 concentrations was USA).
detected as early as 3 h after stimulation (data not shown). An induction of IL-1a, IL-1b, IL-10 and TNF-a (detection 2 .8.
RNA-isolation and RT-PCR
limit of all ELISA, 7.5 pg / ml) release after stimulation with LPS was not observed at all analyzed time points Confluent monolayers of HCAEC cultured in six-well (data not given). plates with 2 ml complete medium were stimulated with 100 ng / ml LPS for 2, 4, 6 or 8 h. Thereafter cells were 3 .2. LPS induces mRNA expression of IL-1b and TNF-a harvested with EDTA and mRNA was extracted using but not of IL-10 oligo-dT magnetic beads according to the manufacturer's instructions (Dynal, Skoyen, Norway). cDNA was preSince the stimulation of HCAEC with LPS did not lead pared by reverse transcription (Superscript Reverse Tranto a detectable release of IL-1b, IL-10, and TNF-a by scriptase, Life Technologies, Karlsruhe, Germany). After ELISA analysis, their mRNA expression was analysed by incubation of 10 ml of the mRNA with 1.0 ml Oligo dT RT-PCR. In contrast to IL-10 mRNA, IL-1b and TNF-a 20 (0.5 mg/ml), the premixed reverse transcription enzyme mRNA were time-dependently upregulated (Fig. 2) . Com- pared to TNF-a, mRNA expression of IL-1b was more respect to the expression of adhesion molecules. Cells pronounced but delayed until 4 hours after stimulation.
were stimulated with increasing concentrations of LPS for 6 h and expression of ICAM-1, VCAM, ELAM-1 and 3 .
LPS induces expression of ICAM-1, VCAM and
LFA-1 were measured by flow cytometry. HCAEC showed ELAM-1 a basal expression of ICAM-1 and VCAM which was increased following stimulation with LPS (Table 1) . We also investigated the response of HCAEC with ELAM-1 was only detected in stimulated cells (Table 1) right heart failure contributes significantly to the disease progress. This has been proposed as the endotoxin hypothwhile LFA-1 was not expressed at a detectable level in esis of CHF [24] [25] [26] . stimulated or unstimulated cells (Table 1) .
Several cytokines exert negative effects on cardiac contractile performance. Among the cytokines which de-3 . 4 
. LPS-induced cytokine expression is mediated by
teriorate contractility are IL-6 and TNF-a [8, 12] . These TLR4 cytokines may result from activated monocytes in the myocardium and insufficently perfused non-vital tissues. On monocytes, LPS interacts with a receptor complex However, it is highly likely that cardiac cells may also consisting of CD14, CD11 / CD18, TLR4, and CD55 become activated when potent stimulants circulate. In fact, [17, 19, 31, 32] . However, on the cell surface of HCAEC, we these cells may no longer act as mere targets of the could detect CD55 but neither CD14 nor TLR4 by flow circulating cytokines but may become active players in the cytometry (Fig. 3A) . In contrast, these three receptors were pro-inflammatory vicious circle. identified on monocytes. Consequently, expression of
In this investigation, we are able to confirm that indeed CD14 and TLR4 was tested at the mRNA level. Using HCAEC become activated when exposed to LPS as was RT-PCR, TLR4 mRNA was detected in all HCAEC shown earlier by other groups [38] [39] [40] . By actively preparations while CD14 was not (Fig. 3B) .
secreting multiple chemokines and cytokines, the activated To test the hypothesis that LPS-induced activation in HCAEC may contribute to the cardiovascular disease HCAEC is mediated by TLR4, we antagonized LPSprogression. The endothelial cells closely neighbor induced activation with Compound 406, the synthetic lipid myocardial cells. Thus, it is reasonable to speculate that A precursor lipid IVa. Recently, it has been demonstrated the local concentrations of cytokines secreted by HCAEC that LPS antagonists act at the level of TLR4 [33] . may contribute to the symptomatic response in addition to Preincubation of HCAEC with Compound 406 completely the circulating cytokines. Activation by LPS also results in inhibited LPS-induced IL-6 release (Fig. 4) , thus demona distinct expression of adhesion molecules, a function of strating on a functional level the involvement of TLR4 in the chemokine and cytokine elevations observed in CHF the LPS-induced activation of HCAEC. Inhibition was also and CAD [41, 42] . It may be that with different stimuli, observed for IL-8 and MCP-1 secretion (data not shown). different results may be found. Although the activation of HCAEC by bacterial cell wall 3 .
Cerivastatin inhibits LPS-induced IL-6 release
components of Gram-negative bacteria is well established, the signal transduction pathways involved remain unclear. HMG CoA reductase inhibitors modulate inflammatory Recently, a low CD14 expression on umbilical vein processes [34, 35] . We therefore tested whether the HMG endothelial cells was reported [43] but our findings confirm CoA reductase inhibitor Cerivastatin affects LPS-induced earlier results that CD14 is not expressed on endothelial cytokine expression in HCAEC. Pre-incubation of the cells cells [18] . Furthermore, we could demonstrate the expreswith different concentrations of Cerivastatin reduced both sion of TLR4 mRNA in HCAEC. However, we failed to basal and LPS-induced expression of IL-6 (Fig. 5) .
detect TLR4 protein expression on the cell surface as determined by flow cytometry which might be due to a very low numbers of receptors expressed. Nevertheless, the pneumonia [34] . These experimental results were conalso reduce the inflammatory effect induced by LPS. In our firmed and reported by many others and also correspond to present investigation, we could demonstrate that also clinical observations that the beneficial effects of statins during pro-inflammatory activation of HCAEC by LPS, may not be due only to the lipid lowering properties [44] .
statins are highly effective in reducing the inflammatory Albert et al. and Jialal et al. reported a decrease in CRP activation. The levels of Cerivastatin plasma concentration protein in patients treated with statins [45, 46] . In patients reached during conventional therapy are around 3.3-3.8 with CAD, statins not only lower CRP levels but also mg / l [50] , which equals a concentration of 6.9-7.9 nM levels of IL-6 and soluble P-selectin [47] . In murine [48] Cerivastatin. Although this is just below the effective and rat [49] models of myocardial infarction, statins have concentration range in our experiments, the effects of been shown to improve left ventricular remodeling and Cerivastatin in vivo compared to the effects obtained in heart failure. We therefore wanted to know if statins may cell culture may not necessarily be achieved within the same concentration range, and might depend on a variety of factors, e.g. plasma proteins that influence the bioavailability of Cerivastatin. Thus, our observations support the idea that, although lipoproteins may have some protective effects in binding and neutralizing endotoxin released from the intestine, patients with CHF might also benefit from the treatment with statins [51] . However, the mechanisms how statins reduce IL-6 release from LPS-activated HCAEC are unclear. The pleiotropic effects of Cerivastatin include the inhibition of the small GTP-binding proteins Rho, Ras, and Rac [44] . However, the main intracellular TLR4 signaling cascade includes the binding of the adaptor protein MyD88, the exact mechanism is not known [44] . Since MAPK can also on different days (n53, data not shown) with comparable results. Pvalues ,0.05 (*) were considered statistically significant. be activated by small GTP-binding proteins, it may be hypothesized that the connection of both signal transduction pathways is possible at this point. This hypothesis is supported by the findings of Takata et al. who demonstrated the inhibition of the p42 / p44 MAPK by pravastatin in human aortic endothelial cells stimulated with thrombin [52] . The question if the action of Cerivastatin is related to or independent from TLR4 signaling pathways has to be addressed in further experiments.
In summary, we have found evidence for a direct involvement of coronary endothelial cells in LPS-mediated inflammatory activation that could facilitate progression of CHF.
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